Showing results (241-250 of 431) with videos related to
Sort By:
Pageof 44
Medchemcomm|March 13, 2012
The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor AgonistsErika E Englund, Susanne Neumann, Elena Eliseeva, et al.Actas Espanolas De Psiquiatria|February 3, 2021
Three-year prevalence of self-harm behaviors among the reasons for emergency visits of children and adolescentsMarc Ferrer, Benjamín Lara, Natalia Calvo, et al.Plos One|August 25, 2016
Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion ProteinsAntonella Antignani, Lesley Mathews Griner, Rajarshi Guha, et al.Stem Cells Translational Medicine|May 31, 2014
A multiplex high-throughput gene expression assay to simultaneously detect disease and functional markers in induced pluripotent stem cell-derived retinal pigment epitheliumMarc Ferrer, Barbara Corneo, Janine Davis, et al.ACS Pharmacology & Translational Science|April 16, 2021
Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput ScreeningGangling Liao, Wenjuan Ye, Tyler Heitmann, et al.Biorxiv : the Preprint Server for Biology|June 26, 2025
Design of peptide-based PAC1 antagonists combining molecular dynamics simulations and a biologically relevant cell-based assayWenqin Xu, Abigail M Keith, Wenjuan Ye, et al.Biochemical Pharmacology|September 5, 2025
Design of peptide-based PAC1 antagonists combining molecular dynamics simulations and a biologically relevant cell-based assayWenqin Xu, Abigail M Keith, Wenjuan Ye, et al.Journal of Biomolecular Screening|August 29, 2012
A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cellsLesley A Mathews, Jonathan M Keller, Bonnie L Goodwin, et al.Nature Communications|June 15, 2013
Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1Jingbo Xiao, Zaohua Huang, Catherine Z Chen, et al.Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitorsAmanda P Skoumbourdis, Christopher A Leclair, Eduard Stefan, et al.Pageof 44